| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $68K | +317.0% |
| Cost of Revenue | $89K | +556.4% |
| Gross Profit | -$21K | -885.1% |
| R&D Expense | $211K | +3107.7% |
| SG&A Expense | $669K | -35.7% |
| Operating Income | -$10.4M | +6.7% |
| Pre-tax Income | -$16.3M | -38.7% |
| Net Income | -$16.3M | -38.7% |
| EPS (Basic) | -$22.81 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $490K | -87.4% |
| Inventory | $42K | +9.2% |
| Current Assets | $1.3M | -69.0% |
| Total Assets | $10.8M | -38.0% |
| Current Liabilities | $4.3M | -28.5% |
| Long-term Debt | $1.5M | -87.0% |
| Total Liabilities | $4.7M | -47.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.3M | +19.0% |
| Investing Cash Flow | -$1.9M | -731.0% |
| Financing Cash Flow | $3.6M | -56.4% |
| -125.6% |
| EPS (Diluted) | -$28.84 | -185.3% |
| Stockholders' Equity |
| $6.1M |
| -28.6% |